NGR-IFN-gamma (MolMed)

N/A

Report date: 2025/03/20 16:12:37

Base Information

Drug NameNGR-IFN-gamma (MolMed)
Drug Alias Namevascular targeting IFN-gamma therapy (MolMed)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAminopeptidase N modulatorsInterferon gamma receptor stimulants
TargetsInterferon gamma receptorAminopeptidase N
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAgc Biologics
China Registration ClassN/A

Develop Information

Active CompaniesAgc Biologics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A